Harald Gollnick
Papers
4
Total Citations
556
H-Index
4
About
Harald Gollnick is a dermatology researcher whose work bridges clinical medicine and advanced imaging technology, with a particular focus on psoriasis pathophysiology and treatment. He is best known for his contributions to the application of Multi-Epitope Ligand Cartography (MELC) robot microscopy — an automated multidimensional fluorescence imaging platform that enables detailed topological and functional analysis of complex tissue proteomes. His landmark 2006 paper on this technology has garnered nearly 500 citations, reflecting its broad adoption across biomedical research communities. Gollnick has applied these cutting-edge imaging methods to clinically meaningful questions, most notably investigating the mechanisms of action of efalizumab (Raptiva) in psoriatic skin. His studies mapped the CD11a binding sites of efalizumab within psoriatic plaques and tracked lymphocyte subpopulation dynamics in peripheral blood during treatment, providing rare molecular-level insight into how this immunomodulatory therapy reshapes the inflammatory microenvironment. His pilot clinical investigations demonstrated that efalizumab was well tolerated and effective, with treated patients showing dramatic reductions in PASI scores. Through this body of work, Gollnick has meaningfully advanced both the technological toolkit for tissue proteomics and the mechanistic understanding of targeted psoriasis therapies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4